Applied DNA Sciences (NASDAQ: APDN) Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed
March 2nd, 2020
News
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
Applied DNA Announces Receipt of International Patents on its Beacon® Secure Optical Molecular Marker Technologies
February 24th, 2020
CertainT®: Be Definite About Your Dietary Supplement Ingredients
February 21st, 2020
APDN Receives Kosher Certification from OU for Qualifying Products
February 20th, 2020
Applied DNA Receives Kosher Certification from Orthodox Union for Qualifying Products
February 20th, 2020
Applied DNA Enters Dietary Supplements Market with Multi-year Nutrition21 Contract
February 19th, 2020
Applied DNA To Speed Up Coronavirus Countermeasures
February 13th, 2020
Applied DNA, Takis Biotech partner on coronavirus vaccine
February 11th, 2020
Applied DNA Sciences Subsidiary, LineaRx, and Takis Biotech Collaborate for Development of a Linear DNA Vaccine Candidate Against Wuhan Coronavirus 2019-nCoV
February 7th, 2020